121 related articles for article (PubMed ID: 9046982)
1. The niacin challenge test: clinical manifestation of altered transmembrane signal transduction in schizophrenia?
Hudson CJ; Lin A; Cogan S; Cashman F; Warsh JJ
Biol Psychiatry; 1997 Mar; 41(5):507-13. PubMed ID: 9046982
[TBL] [Abstract][Full Text] [Related]
2. The niacin challenge test in schizophrenia: past, present and future.
Lin A; Hudson CJ
Prostaglandins Leukot Essent Fatty Acids; 1996 Aug; 55(1-2):17-9. PubMed ID: 8888118
[TBL] [Abstract][Full Text] [Related]
3. Absent response to niacin skin patch is specific to schizophrenia and independent of smoking.
Liu CM; Chang SS; Liao SC; Hwang TJ; Shieh MH; Liu SK; Chen WJ; Hwu HG
Psychiatry Res; 2007 Aug; 152(2-3):181-7. PubMed ID: 17459487
[TBL] [Abstract][Full Text] [Related]
4. Endophenotype properties of niacin sensitivity as marker of impaired prostaglandin signalling in schizophrenia.
Smesny S; Klemm S; Stockebrand M; Grunwald S; Gerhard UJ; Rosburg T; Sauer H; Blanz B
Prostaglandins Leukot Essent Fatty Acids; 2007 Aug; 77(2):79-85. PubMed ID: 17904833
[TBL] [Abstract][Full Text] [Related]
5. Brain potential evidence for an auditory sensory memory deficit in schizophrenia.
Catts SV; Shelley AM; Ward PB; Liebert B; McConaghy N; Andrews S; Michie PT
Am J Psychiatry; 1995 Feb; 152(2):213-9. PubMed ID: 7840354
[TBL] [Abstract][Full Text] [Related]
6. Assessment of basic symptoms in schizophrenia, schizoaffective and bipolar disorders.
Ricca V; Galassi F; La Malfa G; Mannucci E; Barciulli E; Cabras PL
Psychopathology; 1997; 30(1):53-8. PubMed ID: 9042683
[TBL] [Abstract][Full Text] [Related]
7. Niacin skin flush test: a research tool for studying schizophrenia.
Nadalin S; Buretić-Tomljanović A; Rubesa G; Tomljanović D; Gudelj L
Psychiatr Danub; 2010 Mar; 22(1):14-27. PubMed ID: 20305586
[TBL] [Abstract][Full Text] [Related]
8. Membrane phospholipid metabolism and schizophrenia: an in vivo 31P-MR spectroscopy study.
Stanley JA; Williamson PC; Drost DJ; Carr TJ; Rylett RJ; Morrison-Stewart S; Thompson RT
Schizophr Res; 1994 Oct; 13(3):209-15. PubMed ID: 7841133
[TBL] [Abstract][Full Text] [Related]
9. Auditory P300 event-related potentials and neuropsychological performance in schizophrenia and bipolar affective disorder.
Souza VB; Muir WJ; Walker MT; Glabus MF; Roxborough HM; Sharp CW; Dunan JR; Blackwood DH
Biol Psychiatry; 1995 Mar; 37(5):300-10. PubMed ID: 7748981
[TBL] [Abstract][Full Text] [Related]
10. Niacin test in schizophrenia and affective illness.
Rybakowski J; Weterle R
Biol Psychiatry; 1991 Apr; 29(8):834-6. PubMed ID: 2054456
[No Abstract] [Full Text] [Related]
11. Phospholipid membrane abnormalities and reduced niacin skin flush response in schizophrenia.
Buretić-Tomljanović A; Giacometti J; Nadalin S; Rubesa G; Vulin M; Tomljanović D
Psychiatr Danub; 2008 Sep; 20(3):372-83. PubMed ID: 18827766
[TBL] [Abstract][Full Text] [Related]
12. [Personality profile in bipolar schizoaffective psychoses. A comparison with bipolar affective psychoses].
Thau K; Lenz G; Rieder N; Kubinger K; Grisar E
Nervenarzt; 1991 Nov; 62(11):682-8. PubMed ID: 1770968
[TBL] [Abstract][Full Text] [Related]
13. The niacin skin flush test in schizophrenia: a replication study.
Puri BK; Easton T; Das I; Kidane L; Richardson AJ
Int J Clin Pract; 2001; 55(6):368-70. PubMed ID: 11501224
[TBL] [Abstract][Full Text] [Related]
14. Niacin skin flushing in schizophrenic and depressed patients and healthy controls.
Bosveld-van Haandel L; Knegtering R; Kluiter H; van den Bosch RJ
Psychiatry Res; 2006 Aug; 143(2-3):303-6. PubMed ID: 16837062
[TBL] [Abstract][Full Text] [Related]
15. P300 topography differs in schizophrenia and manic psychosis.
Salisbury DF; Shenton ME; McCarley RW
Biol Psychiatry; 1999 Jan; 45(1):98-106. PubMed ID: 9894581
[TBL] [Abstract][Full Text] [Related]
16. The confusion between bipolar disorder and schizophrenia in youth: where does it stand in the 1990s?
Carlson GA; Fennig S; Bromet EJ
J Am Acad Child Adolesc Psychiatry; 1994 May; 33(4):453-60. PubMed ID: 8005897
[TBL] [Abstract][Full Text] [Related]
17. The niacin skin flush abnormality in schizophrenia: a quantitative dose-response study.
Messamore E; Hoffman WF; Janowsky A
Schizophr Res; 2003 Aug; 62(3):251-8. PubMed ID: 12837522
[TBL] [Abstract][Full Text] [Related]
18. Increased phospholipase A2 activity in schizophrenia with absent response to niacin.
Tavares H; Yacubian J; Talib LL; Barbosa NR; Gattaz WF
Schizophr Res; 2003 May; 61(1):1-6. PubMed ID: 12648730
[TBL] [Abstract][Full Text] [Related]
19. Premorbid social functioning in schizophrenia and bipolar disorder: similarities and differences.
Cannon M; Jones P; Gilvarry C; Rifkin L; McKenzie K; Foerster A; Murray RM
Am J Psychiatry; 1997 Nov; 154(11):1544-50. PubMed ID: 9356562
[TBL] [Abstract][Full Text] [Related]
20. Executive functioning in schizophrenia: a thorough examination of performance on the Hayling Sentence Completion Test compared to psychiatric and non-psychiatric controls.
Joshua N; Gogos A; Rossell S
Schizophr Res; 2009 Oct; 114(1-3):84-90. PubMed ID: 19541454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
